Literature DB >> 18853848

Diagnostic value of whole body diffusion weighted imaging for screening primary tumors of patients with metastases.

Tai-Fu Gu1, Xin-Lan Xiao, Fei Sun, Jian-Hua Yin, Hai Zhao.   

Abstract

OBJECTIVE: To evaluate the values of whole body diffusion weighted imaging (DWI) in screening primary unknown tumor in patients with metastases.
METHODS: Totally, 34 patients with metastases of primary unknown tumors were scanned with whole body DWI, and conventional magnetic resonance (MR) imaging was performed if suspected lesions were detected. All the metastases including 27 cases of osseous metastases, 2 brain metastases, 2 liver metastases, 1 pulmonary multiple metastasis, 1 neck metastasis and 1 malignant ascites, were diagnosed by computed tomography, single photon emission computed tomography, or MR imaging. For the proven primary tumors diagnosed by biopsy or pathology of surgical specimens, apparent diffusion coefficient (ADC) values of the primary and metastatic lesions were measured respectively. The sensitivity and specificity of this technique for screening primary tumors were evaluated.
RESULTS: We found 24 cases with suspected primary lesions, in which 23 lesions were proved to be primary tumors, and 1 was proved to be benign lesion. And no definite primary lesion was found in 10 cases on whole body DWI, but in which 1 case was diagnosed with primary tumor by biopsy later, and the other 9 cases remained unknown within follow-up of over half a year. The difference was not significant in ADC values between primary and metastatic lesions (P>0.05). The sensitivity and specificity of whole body DWI for searching primary tumors was 95.8% and 90.0%, respectively.
CONCLUSION: Combined with conventional MR scanning, whole body DWI can help to search primary lesions of patients with metastases.

Entities:  

Mesh:

Year:  2008        PMID: 18853848     DOI: 10.1016/s1001-9294(09)60029-8

Source DB:  PubMed          Journal:  Chin Med Sci J        ISSN: 1001-9294


  2 in total

Review 1.  Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know.

Authors:  Kyung Won Kim; Katherine M Krajewski; Jyothi P Jagannathan; Mizuki Nishino; Atul B Shinagare; Jason L Hornick; Nikhil H Ramaiya
Journal:  AJR Am J Roentgenol       Date:  2013-03       Impact factor: 3.959

Review 2.  FDG PET/CT in carcinoma of unknown primary.

Authors:  Thomas C Kwee; Sandip Basu; Gang Cheng; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-31       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.